Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS, currently impact over 57 million individuals worldwide, a number projected to double every two decades. Despite aging being the predominant risk factor for these debilitating illnesses, the precise molecular underpinnings that link aging to neurodegeneration are not fully understood. A groundbreaking study from researchers at the Salk Institute now illuminates this connection through the creation of the most comprehensive single-cell epigenetic atlas of the aging mouse brain to date. This atlas unveils the fine-scale epigenomic alterations occurring within distinct brain regions and cell types, promising to dramatically empower future research into aging and neurodegenerative conditions.
Aging is accompanied by a cascade of molecular changes, notably including chronic inflammation, mitochondrial dysfunction, genome instability, and profound epigenetic shifts. Epigenetics refers to chemical modifications superimposed on the genome that regulate gene expression without altering the underlying DNA sequence. Among these modifications, DNA methylation has emerged as a key modulator of neuronal function and aging. The Salk team harnessed state-of-the-art single-cell technologies to chart the epigenetic landscape of eight brain regions, profiling over 200,000 cells through assays mapping DNA methylation and chromatin conformation—a measure of the genome’s 3D folding structure. Complementing this, nearly 900,000 cells were spatially profiled via transcriptomics, providing unprecedented resolution into gene expression patterns while preserving tissue architecture.
This newly published atlas in the journal Cell meticulously catalogs epigenetic changes that distinguish younger from aged mouse brains in a cell type-specific manner. It captures 36 distinct brain cell types, ranging from neuronal subtypes to various glial populations. Intriguingly, the data reveal that age-related DNA methylation changes are considerably more pronounced in non-neuronal cells, such as microglia and astrocytes, lymphocytes of the brain’s immune system. This discovery aligns with emerging evidence pointing to glial cells’ pivotal roles in brain aging and neuroinflammation, broadening therapeutic interest beyond neurons alone.
The atlas also identifies transposable elements—commonly known as jumping genes—as major epigenetic hotspots during aging. These repetitive DNA sequences, which comprise roughly half of mammalian genomes, normally remain epigenetically silenced to maintain genomic stability. However, the research reveals significant demethylation of these elements in aged cells, implicating their reactivation as a contributor to cellular dysfunction. This insight lays vital groundwork for considering how loss of transposable element suppression might drive age-associated neurodegenerative pathology.
Beyond methylation, the study integrates chromatin conformation data, spotlighting the spatial organization of the genome. The architecture is partitioned into topologically associating domains (TADs)—subregions within chromosomes that regulate gene expression through physical proximity in 3D space. Remarkably, the Salk team discovered increased TAD boundary strength and enhanced accessibility of CTCF binding sites—CTCF being a critical architectural protein—as biomarkers of brain aging. These changes point to a rewiring of genomic topology that may destabilize transcriptional programs and accelerate age-related decline.
Capturing nearly one million spatially resolved transcriptomes was a tour de force in scale and resolution, enabling the researchers to dissect regional heterogeneity in aging trajectories. An unexpected revelation is the differential aging rates of identical cell types based on their brain location. For instance, glial cells in posterior brain regions exhibited heightened inflammatory gene expression compared to their anterior counterparts. This spatial variance underscores the intricate interplay of local microenvironments with cellular aging, emphasizing that neurodegeneration does not unfold uniformly across the brain.
The methodological innovation of combining multi-omics with spatial transcriptomics represents a significant leap forward in aging research. The data’s spatial dimension preserves the anatomical context, allowing scientists to link molecular alterations to specific neural circuits and brain functions affected in disease. Moreover, by publicly releasing this extensive dataset through Amazon Web Services and the Gene Expression Omnibus, the researchers have democratized access, enabling a global community to probe these aging-related molecular changes without prohibitive computational infrastructure.
The implications for translational science are profound. Using the atlas, the research team developed deep-learning models that predict the trajectory of gene expression changes based on epigenetic signatures. These virtual models could ultimately simulate brain aging, providing a powerful platform for testing interventions before clinical trials. By elucidating precise molecular targets associated with aging and neurodegeneration, this resource opens new avenues for therapeutic development aiming to halt or even reverse brain aging processes.
Senior investigators Joseph Ecker and Margarita Behrens articulate that this cell type-specific epigenetic map delivers a crucial framework for unraveling how aging reshapes neural circuits at the molecular level. As aging profoundly impairs cognition, memory, motor functions, and emotional regulation, deep molecular insight is required to counteract these effects. This atlas paves the way to decipher the mechanisms underlying age-associated neuronal vulnerability and resilience, potentially transforming our approach to widespread neurodegenerative diseases.
In summary, the Salk Institute’s epigenetic atlas integrates methylation, chromatin architecture, and spatial transcriptomics to produce an unparalleled multi-dimensional portrait of the aging brain. By capturing the complexity at single-cell resolution and mapping longitudinal trajectories across regions and cell types, this work heralds a new era of precision neuroscience. Its open-access availability ensures that these rich datasets will catalyze rapid discovery and innovation, accelerating the global quest to understand and ultimately treat neurodegenerative disorders.
Subject of Research: Aging-related epigenetic changes in the mouse brain and their implications for neurodegenerative diseases
Article Title: Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain
News Publication Date: 11-Mar-2026
Web References:
Atlas Data on AWS: https://registry.opendata.aws/salk-aging-mouse-brain-epigeneti/
Journal Article DOI: http://dx.doi.org/10.1016/j.cell.2026.02.015
Image Credits: Salk Institute
Keywords: Neurodegeneration, aging brain, epigenetics, DNA methylation, chromatin conformation, single-cell atlas, transposable elements, spatial transcriptomics, TAD remodeling, CTCF, mouse model, deep learning
Tags: aging-related epigenetic shiftschromatin conformation in brain agingchronic inflammation and brain agingDNA methylation in neuronsepigenomic alterations in neurodegenerationgenome instability and neurodegenerationmitochondrial dysfunction in aging neuronsmolecular changes in aging brainmouse brain single-cell analysisneurodegenerative diseases and agingsingle-cell epigenetic brain atlasspatial profiling of brain cells
